Quantifying the Efficacy and Role of Service Dogs for Military Veterans With PTSD

March 27, 2024 updated by: Maggie O'Haire, University of Arizona
The purpose of this study is to quantify the therapeutic efficacy and role of trained service dogs on socio-emotional functioning among military veterans with posttraumatic stress disorder (PTSD).

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The long-term research goal is to evaluate the safety and efficacy of service dogs as a complementary intervention to enhance biopsychosocial functioning in special populations. The objective is to conduct a methodologically rigorous trial to quantify the therapeutic efficacy of service dogs on clinically-important outcomes for veterans with PTSD. Based on preliminary findings and qualitative reports, the central hypothesis is that military veterans with PTSD who are provided service dogs will experience reduced PTSD symptoms related to socio-emotional functioning and arousal modulation. The rationale for this research is that its successful completion will provide an evidence-based demonstration of the efficacy and role of an increasingly used yet poorly tested complementary intervention. The completion of this project is expected to established an initial demonstration of the therapeutic efficacy of service dogs in this population, as well as possible mechanisms of action via specific biological pathways and human-canine interaction profiles.

Study Type

Interventional

Enrollment (Actual)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Tucson, Arizona, United States, 85721
        • University of Arizona

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria for veterans into the study will include:

  • Applied for and approved to receive a dog from K9s For Warriors
  • Military service on or after September 11, 2001
  • Honorable discharge or current honorable service
  • Diagnosis of PTSD
  • No conviction of any crimes against animals.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Service Dog
Participants in the service dog arm will receive unrestricted, non-study usual care, in addition to a trained service dog.
A service dog trained to perform tasks that are specific to PTSD
No Intervention: Waitlist Control
Participants in the control arm will receive unrestricted, non-study usual care, while on the waitlist for a service dog.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PTSD severity and symptoms via self-report
Time Frame: 3 months
Posttraumatic Stress Disorder Checklist for DSM-V (PCL-5)
3 months
PTSD severity and symptoms via clinician rating
Time Frame: 3 months
Clinician-Administered PTSD Assessment for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition DSM-V (CAPS-5)
3 months
Depression
Time Frame: 3 months
Patient Reported Outcome Measurement Information System (PROMIS) Adult Short Form (SF) v1.0 - Emotional Distress - Depression 8a
3 months
Anxiety
Time Frame: 3 months
Patient Reported Outcome Measurement Information System (PROMIS) Adult Short Form (SF) v1.0 - Emotional Distress - Anxiety 8a
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social isolation
Time Frame: 3 months
Patient Reported Outcome Measurement Information System (PROMIS) Adult Short Form (SF) v2.0 - Social Isolation 8a
3 months
Companionship
Time Frame: 3 months
Patient Reported Outcome Measurement Information System (PROMIS) Adult Short Form (SF) v2.0 - Companionship 6a
3 months
Ability to participate in social activities
Time Frame: 3 months
Patient Reported Outcome Measurement Information System (PROMIS) Adult Short Form (SF) v2.0 - Ability to Participate in Social Roles and Activities 8a
3 months
Mental health quality of life
Time Frame: 3 months
Veterans Rand 12-item Health Survey (VR-12) - Mental Health Component
3 months
Psychological well-being
Time Frame: 3 months
Bradburn Scale of Psychological Wellbeing (BSPW)
3 months
Life satisfaction
Time Frame: 3 months
Satisfaction with Life Scale (SLS)
3 months
Resilience
Time Frame: 3 months
Connor-Davidson Resilience Scale (CDRS)
3 months
Anger
Time Frame: 3 months
Patient Reported Outcome Measurement Information System (PROMIS) Adult Short Form (SF) v1.1 - Emotional Distress - Anger 5a
3 months
Daily socio-emotional experiences
Time Frame: 3 months
Ecological momentary assessment (EMA)
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work and activity participation
Time Frame: 3 months
Work Productivity and Activity Impairment Questionnaire (WPAIQ)
3 months
Suicidal ideation
Time Frame: 3 months
Columbia Suicide Severity Rating Scale (CSSRS)
3 months
Sleep quality
Time Frame: 3 months
Pittsburgh Sleep Quality Assessment (PSQI)
3 months
Sleep disturbance
Time Frame: 3 months
Patient Reported Outcome Measurement Information System (PROMIS) Adult Short Form (SF) v1.0 - Sleep Disturbance 8a
3 months
Sleep actigraphy
Time Frame: 3 months
Actiwatch 2 (Philips Respironics)
3 months
Salivary cortisol awakening response
Time Frame: 3 months
Passive drool method (Salimetrics)
3 months
Electrodermal activity (skin conductance)
Time Frame: 3 months
Embrace wristband (Empatica, Inc.)
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Actual)

June 4, 2020

Study Completion (Actual)

June 4, 2020

Study Registration Dates

First Submitted

July 5, 2017

First Submitted That Met QC Criteria

August 7, 2017

First Posted (Actual)

August 10, 2017

Study Record Updates

Last Update Posted (Actual)

March 29, 2024

Last Update Submitted That Met QC Criteria

March 27, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 1R21HD091896-01 (U.S. NIH Grant/Contract)
  • R21HD091896-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Traumatic Stress Disorder

Clinical Trials on Service Dog

3
Subscribe